Q2 2020 Holdings
Filed 2020-08-14 | 81 holdings | $237.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $84.5M | 2,590,762 | 35.6% |
| Arcturus Therapeutics Hldg I(ARCT) | COM | 03969T109 | $37.4M | 800,000 | 15.7% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $28.8M | 350,000 | 12.1% |
| Ascendis Pharma A S(ASND) | SPONSORED ADR | 04351P101 | $25.9M | 175,000 | 10.9% |
| Cabaletta BIO Inc(CABA) | COM | 12674W109 | $23.5M | 2,105,844 | 9.9% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $15.8M | 70,000 | 6.6% |
| Biontech SE(BNTX) | SPONSORED ADS | 09075V102 | $11.7M | 175,000 | 4.9% |
| Autolus Therapeutics PLC(AUTL) | SPON ADS | 05280R100 | $7.7M | 479,988 | 3.2% |
| Turning Point Therapeutics I | COM | 90041T108 | $176.8K | 2,737,297 | 0.1% |
| Spdr S&P 500 ETF TR(SPY)Put | TR UNIT | 78462F103 | $154.2K | 500,000 | 0.1% |
| Forma Therapeutics Hldgs Inc | SHS | 34633R104 | $152.5K | 3,379,373 | 0.1% |
| Chemocentryx Inc(CCXIEUR) | COM | 16383L106 | $97.8K | 1,700,000 | 0.0% |
| Principia Biopharma Inc(PRNB) | COM | 74257L108 | $95.1K | 1,590,493 | 0.0% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $82.7K | 2,636,661 | 0.0% |
| Ishares TR(IWM)Put | RUSSELL 2000 ETF | 464287655 | $71.6K | 500,000 | 0.0% |
| Y-Mabs Therapeutics Inc(YMABUSD) | COM | 984241109 | $68.0K | 1,574,683 | 0.0% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $67.8K | 2,514,547 | 0.0% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $67.5K | 2,066,108 | 0.0% |
| Viela BIO Inc(VIE) | COM | 926613100 | $65.5K | 1,512,500 | 0.0% |
| Reata Pharmaceuticals Inc(RETAEUR) | CL A | 75615P103 | $62.4K | 400,000 | 0.0% |
| Myokardia Inc | COM | 62857M105 | $58.0K | 600,000 | 0.0% |
| Chemocentryx Inc(CCXIEUR)Call | COM | 16383L106 | $57.5K | 1,000,000 | 0.0% |
| Acceleron Pharma Inc(XLRN) | COM | 00434H108 | $57.2K | 600,000 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $57.1K | 500,000 | 0.0% |
| Spdr SER TR(XBI)Put | S&P BIOTECH | 78464A870 | $56.0K | 500,000 | 0.0% |
| Myovant Sciences LTD | COM | G637AM102 | $51.6K | 2,500,000 | 0.0% |
| Eidos Therapeutics Inc(EIDXGBP) | COM | 28249H104 | $50.3K | 1,055,302 | 0.0% |
| Biohaven Pharmactl Hldg Co L(BHVN) | COM | G11196105 | $43.9K | 600,000 | 0.0% |
| Agenus Inc(AGENEUR) | COM NEW | 00847G705 | $43.2K | 11,000,000 | 0.0% |
| Omeros Corp(OMER) | COM | 682143102 | $40.8K | 2,775,000 | 0.0% |
| Sorrento Therapeutics Inc(SRNE) | COM NEW | 83587F202 | $40.8K | 6,500,000 | 0.0% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $40.5K | 1,701,292 | 0.0% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $30.7K | 1,468,550 | 0.0% |
| Crispr Therapeutics AG(CRSP) | NAMEN AKT | H17182108 | $29.4K | 400,000 | 0.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $27.3K | 350,000 | 0.0% |
| Axonics Modulation Technolog(AXNX*) | COM | 05465P101 | $25.3K | 720,397 | 0.0% |
| Twist Bioscience Corp(TWST) | COM | 90184D100 | $25.0K | 552,849 | 0.0% |
| IGM Biosciences Inc(1K0) | COM | 449585108 | $24.8K | 340,146 | 0.0% |
| Tricida Inc(1T7) | COM | 89610F101 | $24.0K | 872,137 | 0.0% |
| Satsuma Pharmaceuticals Inc | COM | 80405P107 | $23.0K | 798,905 | 0.0% |
| Beam Therapeutics Inc(BEAM) | COM | 07373V105 | $22.0K | 796,429 | 0.0% |
| Quotient LTD | SHS | G73268107 | $21.5K | 2,900,399 | 0.0% |
| ZAI LAB LTD(ZLAB) | ADR | 98887Q104 | $20.5K | 250,000 | 0.0% |
| Uniqure NV(QURE) | SHS | N90064101 | $20.0K | 444,157 | 0.0% |
| Zymeworks Inc | COM | 98985W102 | $19.8K | 550,000 | 0.0% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $19.8K | 885,838 | 0.0% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $19.5K | 99,075 | 0.0% |
| Deciphera Pharmaceuticals in(DCPHEUR) | COM | 24344T101 | $19.0K | 318,914 | 0.0% |
| Pliant Therapeutics, Inc(PLRX) | COM | 729139105 | $18.8K | 611,409 | 0.0% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $17.6K | 110,000 | 0.0% |